Compugen (CGEN) Other Operating Expenses (2009 - 2026)
Compugen (CGEN) posted quarterly Other Operating Expenses of $134000.0 for Q1 2026, down 3.6% year-over-year from $139000.0 in Q1 2025, and up 11.67% on a QoQ basis from $120000.0 in Q4 2025.
Compugen (CGEN) Other Operating Expenses (2009 - 2026) Analysis & Trends
Compugen has reported Other Operating Expenses for 18 years, with the latest figure at $134000.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $134000.0, down 3.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $534000.0 (down 14.42% YoY), and the FY2025 annual result was $539000.0, down 6.42% from the prior year.
- Other Operating Expenses grew to $134000.0 in Q1 2026, from $120000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $13.8 million in Q2 2022 and troughed at $18000.0 in Q3 2023.
- A 5-year average of $937000.0 and a median of $139000.0 in 2025 frame the typical range for Other Operating Expenses.
- The widest annual swing landed in 2022, when Other Operating Expenses surged 5609.13%; it then tumbled 99.64% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at $191000.0 in 2022, then plunged by 68.06% to $61000.0 in 2023, then jumped by 173.77% to $167000.0 in 2024, then dropped by 28.14% to $120000.0 in 2025, then gained by 11.67% to $134000.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $134000.0 in Q1 2026, $120000.0 in Q4 2025, and $139000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 13.76 Mn |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 166,000.00 |
| Jun 30, 2021 | 241,000.00 |